X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Cadila Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs CADILA HEALTHCARE - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA CADILA HEALTHCARE FULFORD INDIA/
CADILA HEALTHCARE
 
P/E (TTM) x 398.8 35.9 1,110.6% View Chart
P/BV x 6.2 9.3 67.2% View Chart
Dividend Yield % 0.1 0.7 12.8%  

Financials

 FULFORD INDIA   CADILA HEALTHCARE
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
CADILA HEALTHCARE
Mar-16
FULFORD INDIA/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs942454 207.3%   
Low Rs450305 147.8%   
Sales per share (Unadj.) Rs691.496.1 719.5%  
Earnings per share (Unadj.) Rs11.514.9 77.1%  
Cash flow per share (Unadj.) Rs15.417.8 86.2%  
Dividends per share (Unadj.) Rs2.003.20 62.5%  
Dividend yield (eoy) %0.30.8 34.1%  
Book value per share (Unadj.) Rs380.052.3 726.9%  
Shares outstanding (eoy) m3.901,023.74 0.4%   
Bonus/Rights/Conversions -FV5:1-  
Price / Sales ratio x1.03.9 25.5%   
Avg P/E ratio x60.725.5 238.0%  
P/CF ratio (eoy) x45.321.3 212.9%  
Price / Book Value ratio x1.87.3 25.2%  
Dividend payout %17.421.5 81.1%   
Avg Mkt Cap Rs m2,714388,458 0.7%   
No. of employees `0000.415.4 2.9%   
Total wages/salary Rs m50513,317 3.8%   
Avg. sales/employee Rs Th6,073.06,371.1 95.3%   
Avg. wages/employee Rs Th1,137.4862.4 131.9%   
Avg. net profit/employee Rs Th100.7986.1 10.2%   
INCOME DATA
Net Sales Rs m2,69698,376 2.7%  
Other income Rs m125941 13.3%   
Total revenues Rs m2,82299,317 2.8%   
Gross profit Rs m-4623,829 -0.2%  
Depreciation Rs m153,022 0.5%   
Interest Rs m10486 2.0%   
Profit before tax Rs m5421,262 0.3%   
Minority Interest Rs m0-300 0.0%   
Prior Period Items Rs m05 0.0%   
Extraordinary Inc (Exp) Rs m0-25 0.0%   
Tax Rs m105,716 0.2%   
Profit after tax Rs m4515,226 0.3%  
Gross profit margin %-1.724.2 -7.1%  
Effective tax rate %17.726.9 65.8%   
Net profit margin %1.715.5 10.7%  
BALANCE SHEET DATA
Current assets Rs m1,73844,376 3.9%   
Current liabilities Rs m54534,071 1.6%   
Net working cap to sales %44.310.5 422.6%  
Current ratio x3.21.3 245.0%  
Inventory Days Days4854 90.0%  
Debtors Days Days462 6.9%  
Net fixed assets Rs m1247,896 0.0%   
Share capital Rs m391,024 3.8%   
"Free" reserves Rs m1,44348,746 3.0%   
Net worth Rs m1,48253,519 2.8%   
Long term debt Rs m08,964 0.0%   
Total assets Rs m2,077100,163 2.1%  
Interest coverage x6.744.7 15.0%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x1.31.0 132.2%   
Return on assets %2.615.7 16.6%  
Return on equity %3.028.4 10.6%  
Return on capital %4.334.3 12.6%  
Exports to sales %045.3 0.0%   
Imports to sales %24.55.9 412.0%   
Exports (fob) Rs mNA44,537 0.0%   
Imports (cif) Rs m6595,838 11.3%   
Fx inflow Rs m1744,881 0.0%   
Fx outflow Rs m6739,069 7.4%   
Net fx Rs m-65635,812 -1.8%   
CASH FLOW
From Operations Rs m9019,938 0.5%  
From Investments Rs m105-9,039 -1.2%  
From Financial Activity Rs m-14-9,527 0.1%  
Net Cashflow Rs m1811,372 13.2%  

Share Holding

Indian Promoters % 0.0 74.8 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 8.3 45.8%  
FIIs % 0.1 5.9 1.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 11.0 192.7%  
Shareholders   4,783 44,069 10.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   DR. DATSONS LABS  DISHMAN PHARMA  J.B.CHEMICALS  JUBILANT LIFE SCIENCES  BIOCON LTD  

Compare FULFORD INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Tata Global Beverages Surges 8.3%(Closing)

Indian share markets snapped their losing streak of last week and finished the trading day on a strong note due to strong buying momentum in FMCG stocks, metal stocks and auto stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 8-QTR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS